View of Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 2: Metabolomic aspects of nephroprotection

Return to Article Details Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 2: Metabolomic aspects of nephroprotection Download Download PDF